ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Carillion Won't Give Up on Balfour Beatty

Share On Facebook
share on Linkedin
Print

At 3:07 pm London time today, Carillion (LSE:CLLN) renewed its wooing of Balfour Beatty (LSE:BBY).  At 3:25 pm, Balfour Beatty’s board responded that it “notes” the Carillion proposal, will consider it, and will make a public response “in due course.” Both Carillion’s share price and Balfour Beatty’s share price responded to the dual announcements, just as they have to similar reports over the past five weeks.

Carillion shares opened at 339.20, up from yesterday’s close of 337.40. Eventually its shares closed at 336.70, down on the day by 0.21%. That, however, does not tell the tale. Three times during the day, the share price had reached or topped 342.60. The last it was at that level was at 2:46. However, within minutes of the price began a dive that bottomed out at 335.30 at 3:34 pm. Oddly, as the shares had fallen to 338.50 at 3:23 and had begun what looked like a turnaround, the clock struck 3:25 and the Balfour response was released, prompting the further decline.

Meanwhile Balfour shares, which had been humming along between 245.0 and 250.00 during most of the day, also took a couple of dramatic afternoon turns. Watch the timing:

  • At 3:07 BBY went from 246.40 to 254.00.
  • By 3:08, just one minute after the CLLN release, it reached 255.10.
  • It continued in that vicinity until Balfour’s response at 3:25, when it once again skyrocketed to 262.40.

Take it for what you will, but there is some significant shareholder interest implied in that reactive pricing.

Carillion noted in its announcement that it had been conducting talks with some of BBY’s major shareholders. This is the same, and somewhat traditional, tactic that AbbVie (NYSE:ABBV) used recently to woo Shire (LSE:SHP). Previously, Balfour had said that the proposal from Carillion was “not in the best interests of Balfour Beatty shareholders” and it list numerous reasons why. Today’s proposal contains specific responses to BBY’s itemized objections.

Essentially, the improved proposal is a:

  • 30% premium on the 24 July closing price
  • 22% premium on the 18 July closing price
  • 36% premium on the one-month Volume-Weighted Average Price prior to 24 July

Other significant details include:

  • A willingness to reimburse up to £10 billion in reasonable bidder’s cost if Balfour’s divestiture of Parsons Brinckerhoff fails as a result of the subject talks.
  • Three Balfour non-executive directors would join the Carillion board
  • The senior management team would be comprised of parties from both companies.
  • An increase from 56.5% share to 58.268% for Balfour shareholders
  • A cash dividend of 8.5 pence per share

There is no doubt that the offer is sweeter, but it remains to be seen if the Balfour board is any more interested than it has been prior to today.

Whether it is the anticipation or a merger or the Balfour faithful believing in the company’s own plan, it is interesting to note that BBY is running ahead of its 200 day moving average (and was before today). Carillion, on the other hand is running below its.

CLICK HERE TO REGISTER FOR FREE ON ADVFN, the world's leading stocks and shares information website, provides the private investor with all the latest high-tech trading tools and includes live price data streaming, stock quotes and the option to access 'Level 2' data on all of the world's key exchanges (LSE, NYSE, NASDAQ, Euronext etc).

This area of the ADVFN.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ADVFN Plc. ADVFN Plc does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ADVFN.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ADVFN.COM and is not intended to be relied upon by users in making (or refraining from making) any investment decisions. Authors may or may not have positions in stocks that they are discussing but it should be considered very likely that their opinions are aligned with their trading and that they hold positions in companies, forex, commodities and other instruments they discuss.

Leave A Reply

 
Do you want to write for our Newspaper? Get in touch: newspaper@advfn.com